Viridian Therapeutics, Inc./DE Short-term Investments
Viridian Therapeutics, Inc./DE (VRDN) had Short-term Investments of $144.57 million as of 2022-03-31, per its 10-Q filed 2022-05-13.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:ShortTermInvestments · last filed 2022-05-13
- 2022-03-31: Short-term Investments $144.57M.
- 2021-12-31: Short-term Investments $154.67M.
- 2021-09-30: Short-term Investments $74.94M.
- 2021-06-30: Short-term Investments $81.60M.
| Period end | Short-term Investments |
|---|---|
| 2022-03-31 | $144.57M 10-Q · filed 2022-05-13 |
| 2021-12-31 | $154.67M 10-Q · filed 2022-05-13 |
| 2021-09-30 | $74.94M 10-Q · filed 2021-11-05 |
| 2021-06-30 | $81.60M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $70.61M 10-Q · filed 2021-05-07 |
| 2020-12-31 | $81.74M 10-K · filed 2022-03-11 |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-12 |
| 2020-06-30 | $0.00 10-Q · filed 2020-08-05 |
| 2020-03-31 | $0.00 10-Q · filed 2020-05-08 |
| 2019-12-31 | $2.00M 10-K · filed 2021-03-26 |
| 2019-09-30 | $8.98M 10-Q · filed 2019-11-08 |
| 2019-06-30 | $19.94M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $32.84M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $29.88M 10-K · filed 2020-03-13 |
| 2018-09-30 | $38.83M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $32.86M 10-Q · filed 2018-08-08 |
| 2017-12-31 | $0.00 10-K · filed 2019-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |